PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2014
CASE
AUTH/2720/6/14 Genzyme

AUTH/2720/6/14: Anonymous v Genzyme β€” discussion of Aubagio monitoring requirements (no breach)

Anonymous complaint alleged a Genzyme employee suggested monthly (off-licence) liver monitoring for Aubagio. Accounts conflicted and evidence was insufficient; the Panel ruled…

2014
CASE
AUTH/2702/3/14 Pfizer ⭐ Case of the Week

AUTH/2702/3/14: General Practitioner v Pfizer β€” remote detailing access via call scheduling (no breach)

A GP alleged a Pfizer representative used subterfuge and urgency to get through to him via reception. The Panel found the call…

2013
CASE
AUTH/2659/11/13 Pfizer

AUTH/2659/11/13: Member of the public v Pfizer β€” Clinical trial disclosure (Conbriza and Xiapex) (No breach after appeal)

Public complaint about alleged late/non-disclosure of trial results for Conbriza and Xiapex. Panel initially found breaches for Xiapex, but Appeal Board ruled…

2016
CASE
AUTH/2835/4/16 Janssen

AUTH/2835/4/16: Janssen voluntary admission over outdated Invokana prescribing information email (No breach)

A mailing agency resent an older Invokana promotional email to GPs with outdated prescribing information. Janssen self-reported, but the Panel ruled no…

2015
CASE
AUTH/2805/12/15 Guerbet Laboratories

AUTH/2805/12/15: Bayer v Guerbet β€” contrast injector β€œloan” deals and Clause 2 discredit

Bayer alleged Guerbet offered CT/MRI contrast injectors as gifts/long-term loans tied to contrast spend. Panel found no breach of Clause 18.1 (no…

2015
CASE
Ferring Pharmaceuticals

Ferring voluntary admission: sales manager drafted hospital letter to GPs promoting DesmoMelt over Desmospray (disguised promotion)

Ferring admitted a sales manager drafted text for hospital consultants to send to GPs recommending DesmoMelt and discouraging Desmospray. Even though no…

2016
CASE
AUTH/2911/11/16 Galen ⭐ Case of the Week

AUTH/2911/11/16: Anonymous (non-contactable) v Galen β€” Promotion of Laxido (No breach)

Anonymous complaint about alleged misleading cost-saving claims, rebates and competitor disparagement in Laxido promotion at a Scottish Prescribers Association meeting. Panel found…

2016
CASE
AUTH/2865/8/16 Sanofi

AUTH/2865/8/16: Anonymous (non-contactable) v Sanofi β€” MEGS nurse advisor service via consultancy company (No breach)

Anonymous complaint alleged industry-funded audits/workshops and coercive behaviour linked to prescribing. Panel found no evidence against Sanofi; its MEGS nurse advisor service…

2012
CASE
Roche Products

Roche: delayed clinical trial results disclosure for BP22572 (Kadcyla/Perjeta) due to misclassification

PMCPA found Roche failed to disclose results of a Phase Ib/IIa trial (BP22572) within required timelines due to internal phase misclassification. Breach…

2017
CASE
AUTH/2931/1/17 Pfizer

Pfizer β€˜Ultimate Stop Smoking Roadshow’ invite: sponsorship clear, but β€˜ultimate’ breached professional standing (AUTH/2931/1/17)

Pulse online ad and emails invited HCPs to a Pfizer-funded stop smoking roadshow. Panel found sponsorship clear and no PI required on…

2016
CASE
AUTH/2923/12/16 Merck Sharp & Dohme

Merck Sharp & Dohme: Remicade ad strapline β€œmore than a name” implied special merit without substantiation (AUTH/2923/12/16)

A hospital pharmacist challenged a Remicade journal ad using a dandelion image and the strapline β€œmore than a name”. Appeal Board found…

2017
CASE
AUTH/2988/10/17 Otsuka ⭐ Case of the Week

Employee v Otsuka (AUTH/2988/10/17): LinkedIn posts promoted POMs to the public and included pre-licence and off-label content

An Otsuka employee used a personal LinkedIn account to share links about tolvaptan and brexpiprazole. The Panel found promotion of POMs to…

2007
CASE
AUTH/2009/6/07 Flynn Pharma

AUTH/2009/6/07: Anonymous v Flynn Pharma β€” Promotion of Medikinet (No breach)

Anonymous complaint about allegedly inappropriate Medikinet mailings, rep calls, and a German clinical paper. Panel found targeting to child psychiatrists/paediatricians reasonable and…

2007
CASE
AUTH/2076/12/07 Abbott Laboratories

AUTH/2076/12/07: Pharmacist v Abbott β€” rep asked for increased Kaletra order to secure Christmas bonus

A hospital pharmacist complained an Abbott rep asked her to increase Kaletra orders so he could get a Christmas bonus. PMCPA ruled…

2007
CASE
AUTH/2037/8/07 Teva

Teva educational meeting on Qvar ruled promotional; omission of paediatric licence limitation found misleading (AUTH/2037/8/07)

At a Teva-sponsored asthma meeting, the Panel said the medical director’s talk was promotional and misleading for omitting that Qvar wasn’t licensed…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training